HEADER TRANSFERASE 31-JUL-07 2V7O TITLE CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TITLE 2 II GAMMA COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II GAMMA COMPND 3 CHAIN; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: KINASE DOMAIN, RESIDUES 5-315; COMPND 6 SYNONYM: CAM-KINASE II GAMMA CHAIN, CAM KINASE II GAMMA SUBUNIT, COMPND 7 CAMK-II SUBUNIT GAMMA, CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II COMPND 8 GAMMA; COMPND 9 EC: 2.7.11.17; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) ROSETTA; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: R3; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS KINASE, S/T KINASE, TRANSFERASE, ATP-BINDING, SERINE/THREONINE- KEYWDS 2 PROTEIN KINASE, NUCLEOTIDE-BINDING, PHOSPHORYLATION, CALMODULIN- KEYWDS 3 BINDING EXPDTA X-RAY DIFFRACTION AUTHOR A.C.W.PIKE,P.RELLOS,O.FEDOROV,N.BURGESS-BROWN,L.SHRESTHA,E.UGOCHUKWU, AUTHOR 2 E.S.PILKA,F.VON DELFT,A.EDWARDS,J.WEIGELT,C.H.ARROWSMITH, AUTHOR 3 M.SUNDSTROM,S.KNAPP REVDAT 6 13-DEC-23 2V7O 1 REMARK LINK REVDAT 5 24-JAN-18 2V7O 1 AUTHOR JRNL REVDAT 4 10-AUG-11 2V7O 1 JRNL REMARK REVDAT 3 13-JUL-11 2V7O 1 VERSN REVDAT 2 24-FEB-09 2V7O 1 VERSN REVDAT 1 11-SEP-07 2V7O 0 JRNL AUTH P.RELLOS,A.C.W.PIKE,F.H.NIESEN,E.SALAH,W.H.LEE,F.VON DELFT, JRNL AUTH 2 S.KNAPP JRNL TITL STRUCTURE OF THE CAMKIIDELTA/CALMODULIN COMPLEX REVEALS THE JRNL TITL 2 MOLECULAR MECHANISM OF CAMKII KINASE ACTIVATION. JRNL REF PLOS BIOL. V. 8 426 2010 JRNL REFN ISSN 1544-9173 JRNL PMID 20668654 JRNL DOI 10.1371/JOURNAL.PBIO.1000426 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.3.0037 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 17388 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 936 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1265 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2417 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 110 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.60000 REMARK 3 B22 (A**2) : -0.43000 REMARK 3 B33 (A**2) : -1.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.243 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.213 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.160 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.480 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2524 ; 0.011 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1706 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3424 ; 1.296 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4123 ; 1.330 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 304 ; 6.366 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 116 ;33.404 ;23.793 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 415 ;14.653 ;15.036 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;18.818 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 369 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2790 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 513 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 458 ; 0.190 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1718 ; 0.180 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1192 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1267 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 97 ; 0.132 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 6 ; 0.259 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 40 ; 0.192 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.192 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -8 A 302 REMARK 3 ORIGIN FOR THE GROUP (A): -17.8350 -36.7440 -5.9950 REMARK 3 T TENSOR REMARK 3 T11: -0.0227 T22: -0.0818 REMARK 3 T33: -0.1926 T12: -0.0031 REMARK 3 T13: 0.0264 T23: 0.0157 REMARK 3 L TENSOR REMARK 3 L11: 0.5622 L22: 2.6013 REMARK 3 L33: 1.0305 L12: 0.2605 REMARK 3 L13: -0.0332 L23: 0.0891 REMARK 3 S TENSOR REMARK 3 S11: -0.0035 S12: 0.0256 S13: 0.1641 REMARK 3 S21: -0.1753 S22: 0.0276 S23: 0.0708 REMARK 3 S31: -0.2573 S32: 0.0334 S33: -0.0241 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2V7O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1290033323. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00721 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18326 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 42.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.72000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1BDW REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.10M MAGNESIUM CHLORIDE, 0.1M HEPES REMARK 280 PH7, 20% PEG6K, 10% ETHYLENE GLYCOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.98400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.98400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 42.35150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 58.61300 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 42.35150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 58.61300 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.98400 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 42.35150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 58.61300 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.98400 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 42.35150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 58.61300 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 SER A -15 REMARK 465 SER A -14 REMARK 465 GLY A -13 REMARK 465 VAL A -12 REMARK 465 ASP A -11 REMARK 465 LEU A -10 REMARK 465 GLY A -9 REMARK 465 ALA A 24 REMARK 465 ALA A 303 REMARK 465 ILE A 304 REMARK 465 LEU A 305 REMARK 465 THR A 306 REMARK 465 THR A 307 REMARK 465 MET A 308 REMARK 465 LEU A 309 REMARK 465 VAL A 310 REMARK 465 SER A 311 REMARK 465 ARG A 312 REMARK 465 ASN A 313 REMARK 465 PHE A 314 REMARK 465 SER A 315 REMARK 465 VAL A 316 REMARK 465 GLY A 317 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A -6 CG OD1 ND2 REMARK 470 LYS A 22 CE NZ REMARK 470 PHE A 25 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 34 CE NZ REMARK 470 THR A 35 OG1 CG2 REMARK 470 LYS A 49 CG CD CE NZ REMARK 470 ARG A 53 CZ NH1 NH2 REMARK 470 GLN A 56 CG CD OE1 NE2 REMARK 470 LYS A 57 CD CE NZ REMARK 470 ARG A 75 CD NE CZ NH1 NH2 REMARK 470 GLU A 83 CD OE1 OE2 REMARK 470 GLU A 106 CG CD OE1 OE2 REMARK 470 TYR A 107 CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 149 CD CE NZ REMARK 470 LYS A 221 CD CE NZ REMARK 470 GLN A 224 CG CD OE1 NE2 REMARK 470 GLU A 286 CD OE1 OE2 REMARK 470 LYS A 299 NZ REMARK 470 LEU A 300 CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 273 CB CYS A 273 SG -0.114 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A -2 -118.64 58.30 REMARK 500 PHE A 17 -144.16 -121.47 REMARK 500 ARG A 135 -1.77 69.89 REMARK 500 ASP A 136 42.12 -149.39 REMARK 500 ASP A 157 81.92 65.17 REMARK 500 LEU A 253 47.62 -87.58 REMARK 500 ARG A 284 77.29 -117.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR A 35 PRO A 36 148.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 BISINDOLYLMALEIMIDE IX (DRN): BIM-9 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DRN A 1303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1305 DBREF 2V7O A -22 0 PDB 2V7O 2V7O -22 0 DBREF 2V7O A 5 315 UNP Q8N4I3 Q8N4I3_HUMAN 5 315 DBREF 2V7O A 316 317 PDB 2V7O 2V7O 316 317 SEQRES 1 A 336 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 336 GLY THR GLU ASN LEU TYR PHE GLN SEP MET ALA THR CYS SEQRES 3 A 336 THR ARG PHE THR ASP ASP TYR GLN LEU PHE GLU GLU LEU SEQRES 4 A 336 GLY LYS GLY ALA PHE SER VAL VAL ARG ARG CYS VAL LYS SEQRES 5 A 336 LYS THR PRO THR GLN GLU TYR ALA ALA LYS ILE ILE ASN SEQRES 6 A 336 THR LYS LYS LEU SER ALA ARG ASP HIS GLN LYS LEU GLU SEQRES 7 A 336 ARG GLU ALA ARG ILE CYS ARG LEU LEU LYS HIS PRO ASN SEQRES 8 A 336 ILE VAL ARG LEU HIS ASP SER ILE SER GLU GLU GLY PHE SEQRES 9 A 336 HIS TYR LEU VAL PHE ASP LEU VAL THR GLY GLY GLU LEU SEQRES 10 A 336 PHE GLU ASP ILE VAL ALA ARG GLU TYR TYR SER GLU ALA SEQRES 11 A 336 ASP ALA SER HIS CYS ILE HIS GLN ILE LEU GLU SER VAL SEQRES 12 A 336 ASN HIS ILE HIS GLN HIS ASP ILE VAL HIS ARG ASP LEU SEQRES 13 A 336 LYS PRO GLU ASN LEU LEU LEU ALA SER LYS CYS LYS GLY SEQRES 14 A 336 ALA ALA VAL LYS LEU ALA ASP PHE GLY LEU ALA ILE GLU SEQRES 15 A 336 VAL GLN GLY GLU GLN GLN ALA TRP PHE GLY PHE ALA GLY SEQRES 16 A 336 THR PRO GLY TYR LEU SER PRO GLU VAL LEU ARG LYS ASP SEQRES 17 A 336 PRO TYR GLY LYS PRO VAL ASP ILE TRP ALA CYS GLY VAL SEQRES 18 A 336 ILE LEU TYR ILE LEU LEU VAL GLY TYR PRO PRO PHE TRP SEQRES 19 A 336 ASP GLU ASP GLN HIS LYS LEU TYR GLN GLN ILE LYS ALA SEQRES 20 A 336 GLY ALA TYR ASP PHE PRO SER PRO GLU TRP ASP THR VAL SEQRES 21 A 336 THR PRO GLU ALA LYS ASN LEU ILE ASN GLN MET LEU THR SEQRES 22 A 336 ILE ASN PRO ALA LYS ARG ILE THR ALA ASP GLN ALA LEU SEQRES 23 A 336 LYS HIS PRO TRP VAL CYS GLN ARG SER THR VAL ALA SER SEQRES 24 A 336 MET MET HIS ARG GLN GLU THR VAL GLU CYS LEU ARG LYS SEQRES 25 A 336 PHE ASN ALA ARG ARG LYS LEU LYS GLY ALA ILE LEU THR SEQRES 26 A 336 THR MET LEU VAL SER ARG ASN PHE SER VAL GLY MODRES 2V7O SEP A -1 SER PHOSPHOSERINE HET SEP A -1 10 HET DRN A1303 33 HET EDO A1304 4 HET EDO A1305 4 HETNAM SEP PHOSPHOSERINE HETNAM DRN BISINDOLYLMALEIMIDE IX HETNAM EDO 1,2-ETHANEDIOL HETSYN SEP PHOSPHONOSERINE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 DRN C25 H23 N5 O2 S FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 HOH *110(H2 O) HELIX 1 1 THR A -8 GLN A -2 1 7 HELIX 2 2 SEP A -1 ALA A 5 5 3 HELIX 3 3 THR A 8 ASP A 13 1 6 HELIX 4 4 SER A 51 LEU A 68 1 18 HELIX 5 5 GLU A 97 ALA A 104 1 8 HELIX 6 6 SER A 109 HIS A 130 1 22 HELIX 7 7 LYS A 138 GLU A 140 5 3 HELIX 8 8 THR A 177 LEU A 181 5 5 HELIX 9 9 SER A 182 LYS A 188 1 7 HELIX 10 10 LYS A 193 GLY A 210 1 18 HELIX 11 11 ASP A 218 ALA A 228 1 11 HELIX 12 12 PRO A 236 VAL A 241 5 6 HELIX 13 13 THR A 242 LEU A 253 1 12 HELIX 14 14 THR A 262 LEU A 267 1 6 HELIX 15 15 HIS A 269 GLN A 274 1 6 HELIX 16 16 GLN A 274 ALA A 279 1 6 HELIX 17 17 ARG A 284 GLY A 302 1 19 SHEET 1 AA 5 TYR A 14 LYS A 22 0 SHEET 2 AA 5 SER A 26 LYS A 33 -1 O VAL A 28 N LEU A 20 SHEET 3 AA 5 GLN A 38 ASN A 46 -1 O GLN A 38 N LYS A 33 SHEET 4 AA 5 PHE A 85 ASP A 91 -1 O HIS A 86 N ILE A 45 SHEET 5 AA 5 LEU A 76 SER A 81 -1 N HIS A 77 O VAL A 89 SHEET 1 AB 2 ILE A 132 VAL A 133 0 SHEET 2 AB 2 ILE A 162 GLU A 163 -1 O ILE A 162 N VAL A 133 SHEET 1 AC 2 LEU A 142 LEU A 144 0 SHEET 2 AC 2 VAL A 153 LEU A 155 -1 O LYS A 154 N LEU A 143 LINK C GLN A -2 N SEP A -1 1555 1555 1.33 LINK C SEP A -1 N MET A 0 1555 1555 1.33 CISPEP 1 SER A 235 PRO A 236 0 3.13 SITE 1 AC1 12 LEU A 20 GLY A 21 VAL A 28 ALA A 41 SITE 2 AC1 12 VAL A 74 PHE A 90 ASP A 91 LEU A 92 SITE 3 AC1 12 VAL A 93 GLU A 140 ASP A 157 HOH A2109 SITE 1 AC2 4 ASN A 247 GLN A 251 GLN A 265 HIS A 269 SITE 1 AC3 5 TYR A 231 ASP A 232 PHE A 233 ALA A 258 SITE 2 AC3 5 HOH A2110 CRYST1 84.703 117.226 75.968 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011806 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008531 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013163 0.00000